Amylyx Pharmaceuticals, Inc. (AMLX) Operating margin 2021–2024
Amylyx Pharmaceuticals, Inc. (AMLX) operating margin by fiscal year — reported operating income divided by reported revenue.
-360.2%FY2024 · since FY2021: -29013.3% → -360.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -360.2% | -370.4 pp |
| FY2023 | 10.2% | +915.9 pp |
| FY2022 | -905.7% | +28107.6 pp |
| FY2021 | -29013.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice